Atlas Trials

Carbamazapine for Inherited Erythromelalgia Patients With NaV1.7 Mutations

Clinical trial NCT02214615 · COMPLETED

Trial details

NCT number
NCT02214615
Sponsor
VA Connecticut Healthcare System
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Erythromelalgia
Start date
2014-04-01
Primary completion
2016-07-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.